Serum Immunometabolic Biomarkers Reveal Distinct Phenotypes in Chronic Urticaria
Diagnostics · 13.04.2026 · 16 (8) · 1148
DOI: 10.3390/diagnostics16081148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 13.04.2026. Verfasst von Nilay Duman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, Ege University, Bornova, 35100 İzmir, Türkiye. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ege University, Ege University Scientific Research Projects Coordination Unit.
Abstract (Originalsprache)
Background/Objectives: Chronic urticaria (CU) is a heterogeneous inflammatory disorder generally attributed to mast cell activation. However, emerging evidence suggests that metabolic reprogramming and systemic immune dysregulation also contribute to the disease pathophysiology. This study aimed to investigate the interplay between epithelial barrier integrity, innate immune regulation, metabolic activity, and mast cell effector mechanisms in CU.
Methods
Forty CU patients and 40 healthy controls were evaluated. Clinical parameters included disease severity, disease subtype, antihistamine response, IgE levels, anti-TPO status, gastrointestinal symptoms, and angioedema. Serum levels of histamine, intestinal fatty acid-binding protein (IFABP), soluble CD14 (sCD14), diamine oxidase (DAO), D-lactic acid, endotoxin, zonulin, calprotectin, and related ratios were measured. Disease activity and control were assessed using the UAS7 and UCT scores.
Results
CU patients exhibited significantly higher DAO (p = 0.003) and lactic acid (p = 0.004) levels compared to controls, whereas other markers showed no significant differences. In anti-TPO-positive patients, sCD14 levels were reduced (p = 0.024), while histamine/sCD14 (p = 0.005), lactic acid/sCD14 (p = 0.014), IFABP/sCD14 (p = 0.008), and zonulin/sCD14 (p = 0.027) were significantly elevated, suggesting relative amplification of metabolic and barrier-related signals under impaired innate immune regulation. Severe anti-TPO-positive patients exhibited lower sCD14 (p = 0.022) and NLR (p = 0.013) but higher UAS7 (p = 0.032), histamine (p = 0.011), calprotectin (p = 0.041), and CD14-normalized ratios, including histamine (p = 0.003), IFABP (p = 0.028), lactic acid (p = 0.019), zonulin (p = 0.029), and calprotectin (p = 0.011) compared with severe anti-TPO-negative patients, indicating a mast cell-dominant and metabolically active inflammatory phenotype. The lactic acid/DAO ratio was significantly lower in controlled versus uncontrolled CU (p = 0.013) and showed discriminatory potential for disease control. Patients with angioedema had higher CRP (p = 0.038) and UAS7 scores (p < 0.001).
Conclusions
CU exhibits marked immunometabolic heterogeneity. Elevated DAO and lactic acid indicate increased histamine turnover and metabolic activation, whereas altered sCD14-normalized biomarker profiles reveal immune dysregulation in anti-TPO-positive patients. Severe CU with features suggestive of thyroid autoimmunity manifests as a mast cell-dominant, metabolically active phenotype with relative suppression of innate immune modulators, contrasting with alternative pathways in other CU phenotypes. The lactic acid/DAO ratio may serve as a candidate biomarker of disease control. These results underscore the importance of phenotype-tailored therapeutic strategies in CU.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Faculty of Medicine, Ege University, Bornova, 35100 İzmir, Türkiye.
- Department of Basic Oncology, Institute of Health Sciences, Ege University, Bornova, 35100 İzmir, Türkiye.
- Faculty of Medicine, Ege University, 35100 İzmir, Türkiye.
- Ataturk Vocational School of Health Services, Ege University, 35100 İzmir, Türkiye.
- Department of Parasitology, Faculty of Medicine, Ege University, Bornova, 35100 İzmir, Türkiye.
ORCID-Profile: Can Muftuoglu, Begüm Tahhan, Deniz Ece, Ayse Caner
Förderung
- Ege University
- Ege University Scientific Research Projects Coordination Unit
Zitieren
APA
Duman, N., Muftuoglu, C., Tahhan, B., Coşkun, T., Ece, D., Mert, U., Özkal, S., & Caner, A. (2026). Serum Immunometabolic Biomarkers Reveal Distinct Phenotypes in Chronic Urticaria. Diagnostics, 16(8), 1148. https://doi.org/10.3390/diagnostics16081148
Vancouver
Duman N, Muftuoglu C, Tahhan B, Coşkun T, Ece D, Mert U, et al. Serum Immunometabolic Biomarkers Reveal Distinct Phenotypes in Chronic Urticaria. Diagnostics. 2026;16(8):1148. doi:10.3390/diagnostics16081148
BibTeX
@article{Duman2026,
author = {Duman, Nilay and Muftuoglu, Can and Tahhan, Begüm and Coşkun, Tolga and Ece, Deniz and Mert, Ufuk and Özkal, Sıla and Caner, Ayse},
title = {Serum Immunometabolic Biomarkers Reveal Distinct Phenotypes in Chronic Urticaria},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {8},
pages = {1148},
doi = {10.3390/diagnostics16081148}
}
EUVIMED